骨科机器人应用的崛起：创新与未来方向

The Rise of Roboticsin Orthopedics Innovations and future directions MAYUR CHODAVADIYA,Global Commercial Lead, IQVIA MedTechMEGHA MAHESHWARI,MedTech Solutions Lead, IQVIA MedTechMOHIT SHEERA, Leader Special Projects – Office of the CEO, Zimmer Biomet Table of contents Introduction1Current state of robotics in orthopedics2Market overview2Robotic penetration into large joint replacements3Competitive landscape3Pros and cons of robotic orthopedic surgery6Future of robotics in orthopedics space7Expert predictions for orthopedic surgery advancements7Future innovations7Economic value8Looking forward9Abbreviations10Methodology10References12About the authors14 Over the past two decades, the MedTech industry has undergone a transformative evolution fueledby significant technological breakthroughs. This progress has spurred the development of various roboticdevices with semi- to fully autonomous assistance functions, aimed at enhancing patient care and improvingsurgeon dexterity. Orthopedic care, which deals with a wide range of musculoskeletal disorders, hasparticularly benefited from these advancements. The intricate complexity of human anatomy and the fragilenature of bones and joints have always made orthopedic conditions challenging to treat. However, roboticsis now playing a crucial role in reshaping how these conditions are treated and rehabilitated. Introduction Building on these advancements, the integrationof robotics into orthopedic care has revolutionizedthe field, offering solutions for enhanced precisionand effectiveness. This evolving partnership promisesa future of greater accuracy, faster recovery periods,and improved overall outcomes. One of the mostsignificant innovations is the creation of robotic-assistedsurgery and navigation systems. These systemsenhance the surgeon’s abilities, enabling more precisebone cutting and alignment—critical for proceduressuch as knee and hip replacements. Robot-assisted surgery (RAS) has made significantstrides since its first attempt in 1985.2Over the pastfour decades, there have been notable advancementsand technological innovations in this field. Althoughthe terms “robotic” and “robot-assisted” are oftenused interchangeably, they do have distinct meanings.Robot-assisted surgeries use a surgeon-controlledsystem, allowing precise operation of the robot froma computer console. In contrast, robotic surgery refersto a more autonomous system where the robot canperform simple tasks like suturing independently,without direct control from a doctor. For simplicity,we will treat both terms as equivalent in this paper. Current state of robotics in orthopedics Robotics in orthopedics goes beyond joint replacements,encompassing spinal surgeries, trauma cases, andsports medicine. These systems assist in complexspinal alignments and fracture fixations, providinggreater control and precision than traditional methods.Research indicates that robotic-assisted spinalsurgeries can enhance accuracy, reduce intraoperativeradiation exposure, and lower complication rates.3 Market overview The global market for robotic orthopedics is experiencingrapid growth. This paper estimates that the globalorthopedic robotics market was valued at over $1.9billion in 2024 and is projected to exceed $3.5 billionby 2030, with a CAGR surpassing 10%. This expansionis driven by the rising prevalence of orthopedicconditions, an aging population, and an increasingpreference for robotic-assisted surgeries. BENEFITS •Enhancedaccuracy and fasterrecoveryperiods•Preciseimplant positioning•Improvedworkflow•Providesergonomic benefits The global orthopedic robotics market has long beendominated by large MNCs.However, players fromemerging economies arerapidly capturing marketshare, especially outside the US While the US leads in joint robotics demand,significant growth is expected in APAC countrieslike Japan, Australia, China, South Korea, andIndia,driven by both established and regionalplayers expanding into these high-growth markets Competitive landscape Robotic penetration into large jointreplacements Stryker and Medtronic are leaders in the robotic largejoint-replacement and robotic spinal fusion markets,respectively. By the end of 2024, 2/3 of Stryker kneesurgeries and 1/3 of Stryker hip surgeries in the USutilized the Mako robotic system.5MAKO Surgical,before its acquisition by Stryker, and Mazor Robotics,before its acquisition by Medtronic, were pioneersin the commercialization of orthopedic surgicalrobots for these segments. Their early market entryenabled them to establish a significant robotic install-base in numerous facilities, supported by their largemultinational parent companies. In Knee procedures, the adoption of robotic technologycontinues to increase, driven by the rising prevalenceof knee disorders that necessitate knee replacements.Observing the successful penetration of Stryker’s MAKOKnee SmartRobotics in recent years, this paper projectsthat other competitors will experience si